MCRB — Seres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · serestherapeutics.com

7.540USD-4.80%Mkt Cap: 73.02M USDP/E: —Last update: 2026-05-26

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhanc…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap73.02M USD

Enterprise Value128.62M USD

Revenue (TTM)1.15M USD

Gross Profit-5.75M USD

Net Income (TTM)5.70M USD

Revenue/Share0.1260 USD

Last Price7.540 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees66

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.78

PEG—

EV/EBITDA-1.53

EV/Revenue112.14

P/S67.96

P/B2.91

EPS (TTM)-5.20

EPS (Forward)-10.28

52W Range

6.5604% of range29.98

52W High29.98 USD

52W Low6.560 USD

Profitability

Gross Margin-729.40%

Oper. Margin-5839.94%

EBITDA Margin0.00%

Profit Margin721.93%

ROE12.88%

ROA4.12%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF1.12M USD

CapEx (TTM)252.00K USD

FCF Margin-3621.47%

FCF Yield-56.89%

Net Debt50.66M USD

Net Debt/EBITDA-0.60

Balance Sheet

Debt/Equity1.88

Current Ratio1.65

Quick Ratio1.55

Book Value/Sh2.763 USD

Cash/Share3.081 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateApr 22, 2025

Analyst Consensus

Rating—

Target (Mean)22.00 USD

Target Range22.00 USD – 22.00 USD

# Analysts1

Ownership

Shares Out.9.68M

Float7.38M

Insiders11.78%

Institutions24.38%

Short Interest

Short Ratio10.6d

Short % Float7.36%

Short % Out.5.61%

Shares Short540.75K

Short (prev mo.)597.31K

Technical

SMA 508.337 (-9.6%)

SMA 20014.07 (-46.4%)

Beta0.12

S&P 52W Chg28.31%

Avg Vol (30d)49.09K

Avg Vol (10d)28.26K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—